179 related articles for article (PubMed ID: 36098911)
1. The influence of prostate volume on clinical parameters in prostate cancer screening.
Shan J; Geng X; Lu Y; Liu Z; Zhu H; Zhou R; Zhang Z; Gang X; Zhang D; Shi H
J Clin Lab Anal; 2022 Oct; 36(10):e24700. PubMed ID: 36098911
[TBL] [Abstract][Full Text] [Related]
2. The influence of age on prostate cancer screening index.
Shan J; Liu Z; Geng X; Feng Y; Yang X; Xu H; Zhou X; Ma W; Zhu H; Shi H
J Clin Lab Anal; 2022 Jan; 36(1):e24098. PubMed ID: 34816496
[TBL] [Abstract][Full Text] [Related]
3. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer.
Zou BZ; Wen H; Luo HJ; Luo WC; Xie QT; Zhou MT
Ir J Med Sci; 2023 Dec; 192(6):2681-2687. PubMed ID: 37414978
[TBL] [Abstract][Full Text] [Related]
4. Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer.
Zhang Q; Li H; Song Z; Kong S; Zhao S; Fan S; Qin F; Ma J
J Int Med Res; 2023 Oct; 51(10):3000605231204429. PubMed ID: 37848343
[TBL] [Abstract][Full Text] [Related]
5. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
Nan LB; Yin XT; Gao JP
Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
[TBL] [Abstract][Full Text] [Related]
6. Clinical research analysis based on prostate cancer screening diagnosis.
Shan J; Geng X; Liu Z; Lu Y; Zhou R; Zhang Z; Xu H; Zhou X; Ma W; Zhu H; Shi H
Andrologia; 2022 May; 54(4):e14371. PubMed ID: 35014705
[TBL] [Abstract][Full Text] [Related]
7. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
Stephan C; Stroebel G; Heinau M; Lenz A; Roemer A; Lein M; Schnorr D; Loening SA; Jung K
Cancer; 2005 Sep; 104(5):993-1003. PubMed ID: 16007682
[TBL] [Abstract][Full Text] [Related]
8. Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone.
Guo ZF; Yang F; Lu XW; Wu JW; He C; Han CH
J Int Med Res; 2021 Jul; 49(7):3000605211019879. PubMed ID: 34308690
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of PSAD and PSAD-TZ value in prostatic hyperplasia and prostatic cancer].
Fu Q; Yao DH; Jiang YQ
Zhonghua Nan Ke Xue; 2002 Dec; 8(6):411-3. PubMed ID: 12593013
[TBL] [Abstract][Full Text] [Related]
10. Total thiol can contribute to differentiating prostate cancer from BPH: Prostate Thiol Index as a new player.
Arpa M; Sen B; Eren H; Uzun H; Okcu O; Erel O
Andrologia; 2021 Nov; 53(10):e14190. PubMed ID: 34270802
[TBL] [Abstract][Full Text] [Related]
11. Is prostate volume better than PSA density and free/total PSA ratio in predicting prostate cancer in patients with PSA 2.5-10 ng/mL and 10.1-30 ng/mL?
Erdogan A; Polat S; Keskin E; Turan A
Aging Male; 2020 Mar; 23(1):59-65. PubMed ID: 30862227
[No Abstract] [Full Text] [Related]
12. The significance of TPSA, free to total PSA ratio and PSA density in prostate carcinoma diagnostics.
Milkovic B; Hadzi-Djokic J; Dzamic Z; Pejcic T
Acta Chir Iugosl; 2007; 54(4):105-7. PubMed ID: 18595240
[TBL] [Abstract][Full Text] [Related]
13. Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
Djavan B; Remzi M; Zlotta AR; Seitz C; Wolfram R; Hruby S; Bursa B; Schulman CC; Marberger M
Tech Urol; 1999 Jun; 5(2):71-6. PubMed ID: 10458658
[TBL] [Abstract][Full Text] [Related]
14. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models.
Chen M; Ma T; Li J; Zhang HJ; Li Q; Wang JJ; Sang T; Cao CL; Cui XW
Med Sci Monit; 2021 Feb; 27():e929913. PubMed ID: 33556045
[TBL] [Abstract][Full Text] [Related]
17. [Significance of prostate central gland/total gland volume ratio combined with PSA in the diagnosis of prostate cancer patients].
Guo ZF; Lu XW; Yang F; Wu JW; Wang H; He C
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2836-2839. PubMed ID: 31550812
[No Abstract] [Full Text] [Related]
18. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
19. Value of the free to total prostate specific antigen ratio and prostate specific antigen density for detecting prostate cancer in Japanese patients.
Maeda H; Arai Y; Okubo K; Aoki Y; Okada T; Maekawa S
Int J Urol; 1998 Jul; 5(4):343-8. PubMed ID: 9712442
[TBL] [Abstract][Full Text] [Related]
20. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml
Wang C; Wang YY; Wang SY; Ding JX; Ding M; Ruan Y; Wang XH; Jing YF; Han BM; Xia SJ; Jiang CY; Zhao FJ
Asian J Androl; 2021; 23(4):415-420. PubMed ID: 33473011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
